You have 9 free searches left this month | for more free features.

Calcitonin Gene-Related Peptide

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Peptide (CGRP) as Biomarker of Migraine

Recruiting
  • Migraine
  • Nociceptive Blink Reflex
  • Greifswald, Germany
    University Medicine Greifswald
Mar 3, 2023

Effect of Drug, Migraine Disorders Trial in Kafr Ash Shaykh (Lacosamide 50 mg)

Recruiting
  • Effect of Drug
  • Migraine Disorders
  • Lacosamide 50 mg
  • Kafr Ash Shaykh, Egypt
    Kafr Elsheikh University Hospital
Nov 20, 2022

Migraine Trial in Copenhagen (Calcitonin Gene-Related Peptide, Erenumab)

Recruiting
  • Migraine
  • Copenhagen, Glostrup, Denmark
    Danish Headache Center
Oct 21, 2022

Migraine, Episodic Migraine, Headache Trial in New York (Click Digital Therapeutic)

Recruiting
  • Migraine
  • +3 more
  • Click Digital Therapeutic
  • New York, New York
    Click Therapeutics
Aug 15, 2023

Post Concussive Symptoms Trial (Early intervention programme, Enhanced usual care)

Active, not recruiting
  • Post Concussive Symptoms
  • Early intervention programme
  • Enhanced usual care
  • (no location specified)
Apr 11, 2023

Anti-CGRP Monoclonal Antibody Response After Switching (AMARAS)

Recruiting
  • Migraine
  • Head Pain
    • Valladolid, Spain
      Hospital Clínico Universitario de Valladolid
    Mar 23, 2023

    Dry Eye, Asthenopia Trial in Torrance (Galcanezumab-gnlm, Ubrogepant)

    Recruiting
    • Dry Eye
    • Asthenopia
    • Torrance, California
      NVision-EWEI-Torrance
    May 31, 2023

    Migraine Trial in Tübingen (High frequency stimulation (HFS), Low-frequency sinusoidal transcutaneous stimulation (sLFS))

    Active, not recruiting
    • Migraine
    • High frequency stimulation (HFS)
    • Low-frequency sinusoidal transcutaneous stimulation (sLFS)
    • Tübingen, Germany
      University Hospital Tübingen
    May 17, 2022

    New Daily Persistent Headache Biomarkers Study

    Terminated
    • New Daily Persistent Headache
    • New Daily Persistent Headache (NDPH)
      • Bronx, New York
        Montefiore Headache Center
      Feb 15, 2022

      CGRP Expression in Human Periodontal Ligament Trial in Bucaramanga (Orthodontic forces)

      Completed
      • CGRP Expression in Human Periodontal Ligament
      • Orthodontic forces
      • Bucaramanga, Metropolitana, Colombia
        Universidad Santo Tomas
      May 10, 2021

      Neurophysiology of Prophylactic Treatment in Migraine

      Completed
      • Migraine
      • antibodies against calcitonin-gene related peptide or its receptor
      • Greifswald, Mecklenburg-Vorpommern, Germany
        Department of Neurology
      May 26, 2021

      Migraine, Migraine Without Aura, Migraine With Aura Trial in Glostrup (Erenumab, Placebo, Calcitonin gene-related peptide)

      Recruiting
      • Migraine
      • +2 more
      • Glostrup, Denmark
        Danish Headache Center
      Oct 6, 2020

      Post-Traumatic Headache, Concussion, Mild Trial in Glostrup (Calcitonin Gene-Related Peptide, Placebo)

      Completed
      • Post-Traumatic Headache
      • Concussion, Mild
      • Calcitonin Gene-Related Peptide
      • Placebo
      • Glostrup, Denmark
        Danish Headache Center
      Jan 27, 2020

      Migraine Trial in Glostrup (Eptinezumab, PACAP-38)

      Recruiting
      • Migraine
      • Glostrup, Denmark
        Danish headache center
      Dec 1, 2022

      Migraine Trial in Glostrup (Calcitonin Gene Related Peptide, Sumatriptan 50 mg, Placebo Oral Tablet)

      Completed
      • Migraine
      • Calcitonin Gene Related Peptide
      • +2 more
      • Glostrup, Denmark
        Rigshospitalet Glostrup
      Sep 11, 2019

      Chronic Migraine, Headache Trial in Alexandria (Lidocaine IV)

      Active, not recruiting
      • Chronic Migraine, Headache
      • Lidocaine IV
      • Alexandria, Egypt
        Alexandria University,Medical Research Institute
      Oct 25, 2023

      Psoriasis Trial in New York (Rimegepant, Placebo)

      Recruiting
      • Psoriasis
      • New York, New York
        Weill Cornell Medicine
      Sep 16, 2022

      Migraine Disorders, Chronic Migraine, Episodic Migraine Trial in Pavia (Monoclonal antibody targeting the CGRP pathway (ligand

      Recruiting
      • Migraine Disorders
      • +2 more
      • Monoclonal antibody targeting the CGRP pathway (ligand or receptor) (mAbs)
      • Pavia, Italy
        Headache Science & Neurorehabilitation Center
      Nov 23, 2023

      Calcitonin, Neuropathic Pain, Spinal Cord Injury Trial in Tanta (Calcitonin, Placebo)

      Not yet recruiting
      • Calcitonin
      • +2 more
      • Tanta, Gharbiya, Egypt
        Tanta University
      Apr 7, 2023

      Neuropeptides and Venous Pelvic Pain

      Active, not recruiting
      • Pelvic Pain
      • +2 more
        • Moscow, Russian Federation
          Department of Faculty Surgery №1
        Sep 20, 2021

        New Persistent Daily Headache Trial (CGRP antibody)

        Not yet recruiting
        • New Persistent Daily Headache
        • CGRP antibody
        • (no location specified)
        Aug 29, 2023

        CGRP Inhibition, Autonomic Function, and Migraine

        Recruiting
        • Episodic Migraine
        • Chronic Migraine
        • Vienna, Austria
          Medical University of Vienna
        Apr 8, 2022

        Migraine; Status Trial in Douliu (Acupressure elastic band (Sea-Band), General elastic band (no bud))

        Completed
        • Migraine; Status
        • Acupressure elastic band (Sea-Band)
        • General elastic band (no bud)
        • Douliu, Yunlin County, Taiwan
          National Taiwan University Hospital Yunlin Branch
        Jul 11, 2022

        Medullary Thyroid Carcinoma, Nodular Goiter Trial in Pilar (Fine Needle Aspiration Cytology (FNAC) procedure+calcitonin

        Completed
        • Medullary Thyroid Carcinoma
        • Nodular Goiter
        • Fine Needle Aspiration Cytology (FNAC) procedure+calcitonin measurement
        • Pilar, Buenos Aires, Argentina
          Hospital Universitario Austral
        Oct 5, 2023

        Migraine Trial in United States (BMS-927711 (CGRP Antagonist))

        Completed
        • Migraine
        • BMS-927711 (CGRP Antagonist)
        • Glendale, California
        • +3 more
        Dec 15, 2022